Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Share This Webinar
About This Webinar
Developing a new gene therapy is rewarding but there are unique challenges ahead. Lack of process templates, scale-up challenges and evolving regulatory guidelines can slow your progress.
We're here to help. With 30+ years of gene therapy experience we bring expertise in viral vector manufacturing and testing as well as a global organization to integrate regulatory, safety, and process development to fit your needs.
Draw on our experience to help overcome your challenges and speed your therapy to patients.
Language:
English
Who can attend? Everyone
Featured Presenters
Senior Product Manager
Viral Gene Therapy product management professional and innovator. Pursuing the industrialization of gene therapy manufacturing to meet the needs of broader patient populations at lower cost. Managing platform production technologies and templated processes.
Product Manager for MilliporeSigma's BioReliance® Viral Vector Manufacturing facility in Carlsbad, California.
Hosted By
The full session archive, available exclusively for attendees of the American Society of Gene & Cell Therapy's 23rd Annual Meeting, May 12-15, 2020.
Documents
Registered (250)